Drug Side Effects

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

This adverse event was reported 611 times

These drugs are most commonly taken by patients reporting EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED:

# Drug Count
0 NIRAPARIB 127
1 PEMBROLIZUMAB 56
2 BEVACIZUMAB 52
3 CARBOPLATIN 43
4 PACLITAXEL 39
5 RIBOCICLIB 39
6 DEXAMETHASONE 34
7 DEXAMETHASONE 1.5 MG 34
8 GABAPENTIN 29
9 ACETAMINOPHEN 26
See all common drugs associated with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METAPROTERENOL SULFATE 1 0.0233
1 AMCINONIDE 1 0.0133
2 NIRAPARIB 127 0.0098
3 ENASIDENIB MESYLATE 15 0.0078
4 SILTUXIMAB 2 0.0074
5 CEDAZURIDINE AND DECITABINE 1 0.0064
6 METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE 1 0.0055
7 RIBOCICLIB 39 0.0035
8 BRIGATINIB 5 0.0031
9 ADO-TRASTUZUMAB EMTANSINE 13 0.0030
See all drugs enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

These drug classes are most commonly taken by patients reporting EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED:

# Drug class Count
0 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 132
1 Kinase Inhibitor [EPC] 71
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 67
3 Corticosteroid [EPC] 65
4 Platinum-based Drug [EPC] 65
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 53
6 Microtubule Inhibitor [EPC] 50
7 Nonsteroidal Anti-inflammatory Drug [EPC] 50
8 Aromatase Inhibitor [EPC] 49
9 Nucleoside Metabolic Inhibitor [EPC] 42
See all common drug classes associated with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-6 Antagonist [EPC] 2 0.0074
1 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 132 0.0062
2 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 5 0.0012
3 Estrogen Receptor Antagonist [EPC] 22 0.0011
4 Programmed Death Ligand-1 Blocker [EPC] 7 0.0009
5 Penem Antibacterial [EPC] 1 0.0008
6 Aromatase Inhibitor [EPC] 49 0.0006
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 67 0.0006
8 HER2/neu Receptor Antagonist [EPC] 26 0.0005
9 Microtubule Inhibitor [EPC] 50 0.0005
See all drug classes enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED